2018 annual financial data

C4 Therapeutics, Inc. 2018 Operating margin

C4 Therapeutics, Inc. 2018 operating margin with verified reported values.

Direct answer

Operating margin was -84.64%.

Operating income was -16,389,000 USD and net income was -15,711,000 USD.
Operating cash flow was -16,981,000 USD.

Get free C4 Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
19,364,000 USD
Operating income
-16,389,000 USD
Net income
-15,711,000 USD
Operating cash flow
-16,981,000 USD